Guardion Health Sciences is a health sciences company that has developed medical foods and medical devices in the ocular health space and that is developing nutraceuticals. Co. formulates and distributes Lumega-Z®, which is designed to replenish and restore the macular protective pigment. Co.'s medical food product, GlaucoCetin is designed to support and protect the mitochondrial function of optic nerve cells and improve blood flow in the ophthalmic artery in patients with glaucoma. Co. invented a proprietary technology, embodied in its medical device, the MapcatSF®, that accurately measures the macular pigment optical density. The GHSI stock yearly return is shown above.
The yearly return on the GHSI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the GHSI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|